stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. PGEN
    stockgist
    HomeTop MoversCompaniesConcepts
    PGEN logo

    Precigen, Inc.

    PGEN
    NASDAQ
    Healthcare
    Biotechnology
    Germantown, MD, US143 employeesprecigen.com
    $3.94
    +0.01(0.13%)

    Mkt Cap $1.2B

    $1.17
    $5.21

    52-Week Range

    At a Glance

    AI-generated

    Precigen, Inc.

    Revenue breakdown: Product And Service (33.6%), Service Exemplar (23.5%), Service (23.5%).

    8-K
    Precigen, Inc. reported full year 2025 financial results, including $3.4 million in PAPZIMEOS net product revenue from its first partial quarter of U.S. commercial sales, total revenues up $5.8 million year-over-year, net loss attributable to common shareholders of $429.6 million or $1.37 per share, and cash, cash equivalents, and investments of $100.4 million as of December 31, 2025.

    $1.2B

    Market Cap

    $6M

    Revenue

    -$250M

    Net Income

    Employees143
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Product And Service33.6%($18M)
    Service Exemplar23.5%($13M)
    Service23.5%($13M)
    Product9.7%($5M)
    Papzimeos6.3%($3M)
    Product Exemplar3.4%($2M)

    Revenue by Geography

    Non Us100%($241.0K)
    Activity

    What Changed Recently

    Financial Results
    Mar 24, 2026

    . Results of Operations and Financial Condition. Attached as Exhibit 99.1 is a copy of a press release of Precigen, Inc., dated March 25, 2026, reporting its fi

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    TERNTerns Pharmaceuticals, In...$52.73-0.12%$4.7B-48.2
    DNTHDianthus Therapeutics, In...$86.51+2.31%$3.3B—
    ELVNEnliven Therapeutics, Inc...$38.72+2.45%$2.3B-16.8
    RLAYRelay Therapeutics, Inc.$12.56+16.67%$2.2B-6.1
    NKTRNektar Therapeutics$77.01+1.72%$1.6B-9.2
    IMTXImmatics N.V.$10.36+3.45%$1.4B-5.5
    WVEWave Life Sciences Ltd.$7.25+6.08%$1.4B-10.2
    AMLXAmylyx Pharmaceuticals, I...$15.02+4.66%$1.2B-8.8
    Analyst View
    Company Profile
    CIK0001356090
    ISINUS74017N1054
    CUSIP74017N105
    Phone301 556 9900
    Address20374 Seneca Meadows Parkway, Germantown, MD, 20876, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice